Journal article
The science of vaccine safety: Summary of meeting at Wellcome Trust.
- Plotkin SA University of Pennsylvania, Vaxconsult, 4650 Wismer Rd., Doylestown, PA 18902, USA. Electronic address: Stanley.plotkin@vaxconsult.com.
- Offit PA The Vaccine Education Center Division of Infectious Diseases, The Children's Hospital of Philadelphia, USA. Electronic address: offit@email.chop.edu.
- DeStefano F Immunization Safety Office, Centers for Disease Control and Prevention, Atlanta, GA, USA.
- Larson HJ The Vaccine Confidence Project, London School of Hygiene & Tropical Medicine, United Kingdom. Electronic address: Heidi.larson@ishtm.ac.uk.
- Arora NK Vaccine Hesitancy Cluster, The INCLEN Trust International New Delhi, India. Electronic address: nkarora@inclentrust.org.
- Zuber PLF Safety and Vigilance (SAV), Access to Medicines, Vaccines and Pharmaceuticals, World Health Organization, 20 Avenue Appia, 1211 Genève 27, Switzerland.
- Fombonne E Oregon Health & Science University, Institute on Development & Disability, USA. Electronic address: fombonne@ohsu.edu.
- Sejvar J Division of High-Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, USA. Electronic address: Zea3@cdc.gov.
- Lambert PH Centre of Vaccinology, University of Geneva, Switzerland. Electronic address: paul.lambert@unige.ch.
- Hviid A Department of Epidemiology Research, Statens Serum Institut, Copenhagen, Denmark. Electronic address: aii@ssi.dk.
- Halsey N Institute for Vaccine Safety, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA. Electronic address: nhalsey1@jhu.edu.
- Garçon N CEO/CSO, BIOASTER, 40 Avenue Tony Garnier, Lyon, France.
- Peden K Laboratory of DNA Viruses, Division of Viral Products, Office of Vaccines Research and Review, Center for Biologics Evaluation and Review, Food and Drug Administration, Silver Spring, MD 20993, USA. Electronic address: keith.peden@fda.hhs.gov.
- Pollard AJ Department of Paediatrics, Vice Master, St Cross College, University of Oxford, Room 02-46-07, Level 2, Children's Hospital, Oxford OX3 9DU, United Kingdom.
- Markowitz LE National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA. Electronic address: lem2@cdc.gov.
- Glanz J Kaiser Permanente Colorado, Institute for Health Research, Colorado School of Public Health, Department of Epidemiology, USA.
- 2020-01-29
Published in:
- Vaccine. - 2020
English
Vaccines are everywhere hugely successful but are also under attack. The reason for the latter is the perception by some people that vaccines are unsafe. However that may be, vaccine safety, life any other scientific subject, must be constantly studied. It was from this point of view that a meeting was organized at the Wellcome Trust in London in May 2019 to assess some aspects of vaccine safety as subjects for scientific study. The objective of the meeting was to assess what is known beyond reasonable doubt and conversely what areas need additional studies. Although the meeting could not cover all aspects of vaccine safety science, many of the most important issues were addressed by a group of about 30 experts to determine what is already known and what additional studies are merited to assess the safety of the vaccines currently in use. The meeting began with reviews of the current situation in different parts of the world, followed by reviews of specific controversial areas, including the incidence of certain conditions after vaccination and the safety of certain vaccine components. Lastly, information about the human papillomavirus vaccine was considered because its safety has been particularly challenged by vaccine opponents. The following is a summary of the meeting findings. In addition to this summary, the meeting organizers will explore opportunities to perform studies that would enlarge knowledge of vaccine safety.
- Language
-
- English
- Open access status
- closed
- Identifiers
-
- DOI 10.1016/j.vaccine.2020.01.024
- PMID 31987690
- Persistent URL
- https://folia.unifr.ch/global/documents/70316
Statistics
Document views: 8
File downloads: